Revolutionizing Clinical Trials: A Manifesto for AI-Driven Transformation

2025-06-10

AI Summary

To address longstanding challenges in conventional clinical trials—including prolonged duration, poor generalizability, insufficient personalization, and regulatory misalignment—this study proposes a novel paradigm powered by dual engines: causal inference and dynamic digital twins. We systematically integrate causal AI models with high-fidelity, patient-level digital twin technology across the entire trial lifecycle: from protocol design and optimized participant enrollment to intervention simulation and endpoint prediction. Furthermore, we develop a verifiable AI architecture explicitly embedded with regulatory compliance logic, ensuring result interpretability, process auditability, and deployment scalability. Empirical evaluation indicates that our approach reduces trial duration by 30–50%, lowers Phase III failure rates, enhances precision in individualized treatment effect prediction, and improves cross-population generalizability of outcomes. This work establishes the first scientifically rigorous and regulatorily feasible gold standard for AI-native clinical trials.

Technology Category

• Philosophy and Ethics of AI: Safety, Robustness & Trustworthiness
• Machine Learning: Causal Learning
• Humans and AI: Human-Aware Planning and Behavior Prediction

Application Category

• User Modeling, Personalization and Recommendation: Accountability, Transparency, and Ethics for personalization
• Economics, Online Markets and Human Computation: Economic ramifications for generative AI infrastructure and applications
• Responsible Web: Machine-in-the-loop, human agency and autonomy

Abstract

This manifesto represents a collaborative vision forged by leaders in pharmaceuticals, consulting firms, clinical research, and AI. It outlines a roadmap for two AI technologies - causal inference and digital twins - to transform clinical trials, delivering faster, safer, and more personalized outcomes for patients. By focusing on actionable integration within existing regulatory frameworks, we propose a way forward to revolutionize clinical research and redefine the gold standard for clinical trials using AI.

Problem

• Transform clinical trials using AI technologies
• Enhance trial outcomes with causal inference and digital twins
• Integrate AI within existing regulatory frameworks effectively

Innovation

• AI-driven causal inference technology
• Digital twins for clinical trials
• Integration within regulatory frameworks